(the list is not exhaustive and will be updated over time)
Respiratory Infections: Influenza, RSV, emerging respiratory viruses including coronaviruses, novel TB vaccines, pertussis, Group A Streptococcus, Streptococcus pneumoniae, Group B Streptococcus, Neisseria meningitidis, nontypable H. Influenzae
Malaria/Tropical Diseases: Malaria, Schistosomiasis, Filariasis, soil-transmitted helminths, Leishmaniasis, novel vector control and interventions; special considerations given to CHIM and International Sites
Enterics: Shigella, Campylobacter, non-typhoidal Salmonella, C. difficile, Cryptosporidium, hepatitis and rotavirus, enteroviruses, norovirus
Sexually Transmitted Infections: N. gonorrhoeae, Chlamydia trachomatis, Syphilis (Treponema pallidum), herpes simplex virus, Trichomonas vaginalis, Mycoplasma genitalium, HPV
Emerging Infections: Coccidioidomycosis, Candida (including C. auris), Ebola, mosquito tick and other borne diseases including dengue, Zika and Lyme Disease; other emerging viruses- Rift valley fever, Lassa, biodefense pathogens (anthrax, botulism, etc.), antibiotic resistant bacterial infections such as Enterobacteriaceae, Staphylococcus aureus, Acinetobacter, Pseudomonas.